Market openNon-fractional

AbbVie/ABBV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About AbbVie

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

Ticker

ABBV

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology

Headquarters

North Chicago, United States

Employees

50,000

AbbVie Metrics

BasicAdvanced
$307B
Market cap
51.65
P/E ratio
$3.36
EPS
0.62
Beta
$6.06
Dividend rate
3.49%
Dividend yield
$307B
0.62
$6.06
0.936
0.723
797.341
924.059
177.71%
7.50%
7.71%
56.24%
51.651
5.64
29.59
-3.95
14.019
3.49%
-4.12%
-20.93%
2.72%
4.87%
6.90%

What the Analysts think about AbbVie

Analyst Ratings

Majority rating from 30 analysts.
Buy

AbbVie Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
11.12% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$12B
-13.92%
Net income
$1.4B
66.55%
Profit margin
11.12%
93.73%

AbbVie Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.76%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.91
$2.95
$2.79
$2.31
-
Expected
$2.81
$2.86
$2.77
$2.23
$3.05
Surprise
3.69%
3.25%
0.84%
3.76%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

Aug
15
AbbVie
Dividend·Payment
$1.55
Per share

FAQs

What’s the current market cap for AbbVie stock?

AbbVie (ABBV) has a market cap of $307B as of July 23, 2024.

What is the P/E ratio for AbbVie stock?

The price to earnings (P/E) ratio for AbbVie (ABBV) stock is 51.65 as of July 23, 2024.

Does AbbVie stock pay dividends?

Yes, the AbbVie (ABBV) stock pays dividends to shareholders. As of July 23, 2024, the dividend rate is $6.06 and the yield is 3.49%. AbbVie has a payout ratio of 177.71% on a trailing twelve-month basis.

When is the next AbbVie dividend payment date?

The next AbbVie (ABBV) dividend payment is scheduled for August 15, 2024.

What is the beta indicator for AbbVie?

AbbVie (ABBV) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell AbbVie stock

Buy or sell AbbVie stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing